Powered by

Selecta Biosciences to reduce 36% of workforce

Jan 03, 2019 - Marketline Newswire
Organizational Restructuring

Selecta Biosciences, Inc. announced that on December 21, 2018, the Board of Directors approved a plan to reduce the company's headcount by approximately 36% following a strategic review of the Company's business.

The Workforce Reduction aims to align Selecta’s workforce with the Company’s newly announced strategy to focus on the development of the Company’s lead product candidate, SEL-212, for the treatment of chronic refractory gout, and advancement of the Company’...